Professor, Pharmacology, Rush Medical College of Rush Univ
Cardiology
Dr. John C. Somberg, MD
|
|
Give Review
John Somberg practices Cardiology. He attended New York Medical College - Metropolitan Hospital Center. John C. Somberg, MD is a published physician. He published 100 publications, including: 'Effects of actodigin on the heart.'
Publications
- Evaluation of the Effects of Different Energy Drinks and Coffee on Endothelial Function.
- Assessment of cardiovascular and noncardiovascular medical device recalls.
- The impact of comorbidities on stroke prophylaxis strategies in atrial fibrillation patients.
- The device development pinata.
- Are we facilitating therapeutic innovation?
- Publication delays.
- Has the food and drug administration changed the drug approval process?
- Gender Differences in Cardiac Repolarization Following Intravenous Sotalol Administration.
- Inappropriate attack on device development.
- Have we maxed out on new therapies.
- The Food and Drug Administration's paternalism.
- The midodrine withdrawal.
- Developing a safe intravenous sotalol dosing regimen.
- Is the device development process adequate.
- The hubris of science: defending the scientific process from political agendas.
- New advances and new questions in cardiovascular therapeutics.
- Medical isotope shortages.
- The extrapolation of study results in the device approval process.
- The stimulus package and medical therapeutics.
- The Management of Acute Heart Failure and Diuretic Therapy.
- The Pleiotropic Effects of Ethacrynic Acid.
- Therapeutic Approaches to the Treatment of Edema and Ascites: The Use of Diuretics.
- The Clinical Pharmacology of Ethacrynic Acid.
- The sins of ghostwriting.
- Securing the US pharmaceutical supply.
- Incidence and predictors of screen Failures due to positive urine tests for alcohol, drugs of abuse, and cotinine among normal healthy research volunteers (NHRVs): ana...
- The cholesterol hypothesis: questioned?
- Risk assessment, drug approval, and liability.
- Pharmaceutical companies and medical therapeutics education.
- An opportunity to distance the FDA from Washington politics.
- Nesiritide: the wrong controversy.
- Chiral cardiovascular drugs: an overview.
- The new drug evaluation process: risk benefit ratio.
- The effect of magnesium sulfate on action potential duration and cardiac arrhythmias.
- Pharmacology and toxicology of a new aqueous formulation of intravenous amiodarone (Amio-Aqueous) compared with Cordarone IV.
- The pharmacologic treatment of Heart failure.
- Comparative effects of rapid bolus administration of aqueous amiodarone versus 10-minute cordarone I.v. infusion on mean arterial blood pressure in conscious dogs.
- Enhancement of myocardial vulnerability by atrial fibrillation.
- A case of herceptin cardiotoxicity.
- The quest for an aqueous amiodarone.
- SARS challenges therapeutics.
- Hypertension therapeutics in turmoil.
- Free exchange of ideas.
- Pediatric drug development.
- Clinical therapeutic conference.
- Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect.
- Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone.
- Biologic problems.
- Arrhythmia therapy.
- Restricting physician prescribing.
- Genetic polymorphisms.
- Old drugs, new bottles, therapeutic advantage?
- Clinical research oversight.
- The generic conundrum.
- Usefulness of QT dispersion as an electrocardiographically derived index.
- Bioterrorism 2002.
- Rapid determination of partition coefficients between n-octanol/water for cardiovascular therapies.
- American Journal of Therapeutics.
- The Year in Review.
- The Therapeutics of Hypertensive Emergency.
- Approaches to Intravenous Nitroglycerin Therapy.
- Gender Differences in Drug Therapy.
- Rational Therapeutics: Dose Titration and Monotherapy in Clinical Practice.
- The FDA and Software.
- Clinical Therapeutic Conference: Therapeutic Considerations in Atrial Fibrillation Management.
- The Commercialization of Research.
- Changing the Regulatory Process.
- Histamine and Antihistamines: Clinical Pharmacology for the Practicing Physician.
- Smoking, Smoking Cessation, and Regulation.
- Smoking Cessation Strategies.
- The Cancer Myth.
- Nonphysician Prescribing.
- Revisiting Adverse Drug Reactions.
- Editorial: Inertia in Clinical Research.
- The Promise of Chirality.
- The Information Age and Therapeutics.
- Clinical Therapeutic Conference: Thyroid Hormone Replacement in Hypothyroidism.
- Off Label Indications.
- Misoprostol and Eicosanoids: A New and Exciting Area of Therapeutics.
- Smoking.
- Clinical Therapeutic Conference: Sudden Death in a Young Athlete.
- Proarrhythmia or Arrhythmogenicity.
- A New Virus and the Adequacy of Public Health Methods.
- Practice Guidelines, Consensus Conferences: The Pros and Cons.
- Panel Discussion.
- The Calcium Channel Blockers.
- The Governmental Revolution.
- Dismantling the FDA.
- Editorial: Deferred Consent: Issues In Clinical Research.
- Editorial: The Basis of Pharmaceutical Approval.
- Editorial: Therapeutics, Clinical Phamacology, Molecular Pharmacology: Have We Lost Our Academic Way?
- Clinical Therapeutic Conference: Vancomycin Nephrotoxicity.
- Pharmacoeconomics: These Changing Times.
- To Begin Again.
- Letter: Drugs for arrhythmias.
- The influence of Heart rate on ouabain cardiotoxicity in cats with spinal cord transection.
- The effect of diphenidol on ouabain cardiotoxicity in the cat.
- Effects of actodigin on the Heart.
- A comparison of actodigin and ouabain in cats.
Schools
New York Medical College
Conditions Treated
- Congestive Heart Failure
- Hypertension
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna
- Medicare MCR
Education
-
Brigham and Women's Hospital -
New York Medical College - Metropolitan Hospital Center -
New York Medical College
Hospital
-
Rush University Medical Center